Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

被引:0
|
作者
Daniel E. Casey
William H. Carson
Anutosh R. Saha
Amy Liebeskind
Mirza W. Ali
Darlene Jody
Gary G. Ingenito
机构
[1] VA Medical Center,Mental Health Division (P3MIRECC)
[2] Otsuka America Pharmaceutical Inc,undefined
[3] Otsuka Maryland Research Institute,undefined
[4] Lenox Hill Hospital,undefined
[5] Bristol-Myers Squibb,undefined
来源
Psychopharmacology | 2003年 / 166卷
关键词
Aripiprazole; Schizophrenia; Atypical antipsychotic; Switching;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:391 / 399
页数:8
相关论文
共 50 条
  • [1] Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study
    Casey, DE
    Carson, WH
    Saha, AR
    Liebeskind, A
    Ali, MW
    Jody, D
    Ingenito, GG
    PSYCHOPHARMACOLOGY, 2003, 166 (04) : 391 - 399
  • [2] Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia
    Ma, Chia-Hao
    Chan, Hung-Yu
    Hsieh, Ming H.
    Liu, Chen-Chung
    Liu, Chih-Min
    Hwu, Hai-Gwo
    Kuo, Ching-Hua
    Chen, Wei J.
    Hwang, Tzung-Jeng
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022, 12
  • [3] Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia
    Cazorla, Pilar
    Mackle, Mary
    Zhao, Jun
    Ha, Xianwei
    Szegedi, Armin
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2012, 8 : 247 - 257
  • [4] Fast Versus Slow Strategy of Switching Patients With Schizophrenia to Aripiprazole From Other Antipsychotics
    Hwang, Tzung-Jeng
    Lo, Wei-Ming
    Chan, Hung-Yu
    Lin, Ching-Feng
    Hsieh, Ming H.
    Liu, Chen-Chun
    Liu, Chih-Min
    Hwu, Hai-Gwo
    Kuo, Ching-Hua
    Chen, Wei J.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (06) : 635 - 644
  • [5] Comparing the Effectiveness and Safety of the Addition of and Switching to Aripiprazole for Resolving Antipsychotic-Induced Hyperprolactinemia: A Multicenter, Open-Label, Prospective Study
    Yoon, Hui Woo
    Lee, Jung Suk
    Park, Sang Jin
    Lee, Seon-Koo
    Choi, Won-Jung
    Kim, Tae Yong
    Hong, Chang Hyung
    Seok, Jeong-Ho
    Park, Il-Ho
    Son, Sang Joon
    Roh, Daeyoung
    Kim, Bo-Ra
    Lee, Byung Ook
    CLINICAL NEUROPHARMACOLOGY, 2016, 39 (06) : 288 - 294
  • [6] Switching strategies for antipsychotic monotherapy in schizophrenia: a multi-center cohort study of aripiprazole
    Obayashi, Yoshiaki
    Mitsui, Satoshi
    Sakamoto, Shinji
    Minao, Nozomu
    Yoshimura, Bunta
    Kono, Toshiki
    Yada, Yuji
    Okahisa, Yuko
    Takao, Soshi
    Kishi, Yoshiki
    Takeda, Toshihiko
    Takaki, Manabu
    Yamada, Norihito
    PSYCHOPHARMACOLOGY, 2020, 237 (01) : 167 - 175
  • [7] Switching strategies for antipsychotic monotherapy in schizophrenia: a multi-center cohort study of aripiprazole
    Yoshiaki Obayashi
    Satoshi Mitsui
    Shinji Sakamoto
    Nozomu Minao
    Bunta Yoshimura
    Toshiki Kono
    Yuji Yada
    Yuko Okahisa
    Soshi Takao
    Yoshiki Kishi
    Toshihiko Takeda
    Manabu Takaki
    Norihito Yamada
    Psychopharmacology, 2020, 237 : 167 - 175
  • [8] Comparison of Fast Versus Slow Strategy in Switching Schizophrenia Patients to Aripiprazole from Other Antipsychotics
    Hwang, Tzung-Jeng
    Chan, Hung-Yu
    Lin, Ching-Feng
    Hsieh, Ming H.
    Liu, Chen-Chun
    Liu, Chih-Min
    Kuo, Ching-Hua
    Chen, Wei J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 191 - 192
  • [9] TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel
    Veznedaroglu, Baybars
    Dilbaz, Nesrin
    Uzun, Ozcan
    Isik, Erdal
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (10) : 271 - 285
  • [10] Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
    Wani, Rayees Ahmad
    Dar, Mansoor Ahmad
    Chandel, Rajesh Kumar
    Rather, Yasir Hassan
    Haq, Inaamul
    Hussain, Arshad
    Malla, Altaf Ahmad
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 685 - 693